Cite

HARVARD Citation

    Mao, Z. et al. (2018). Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?. Multiple sclerosis journal, experimental, translational and clinical. 4 (2), p. . [Online]. 
  
Back to record